Tag: population

Wuppertal, Germany, August 5, 2025 - Aicuris Anti-infective Cures AG today announced initial clinical data from its ongoing first-in-human Phase 1 trial with AIC468. The novel antiviral antisense oligonucleotide is in development for the treatment of BK virus (BKV) infections in kidney transplant recipients. The interim results, presented at the World Transplant Congress in San Francisco on August 4, 2025, provide an overview of PK characteristics of AIC468 from the Phase 1 clinical trial in healthy volunteers.

Press Release

A powerful surge in online searches for natural sciatica remedies has thrust Sciaticyl into the spotlight, thanks to a peculiar “nerve reset” approach linked to ancient herbal wisdom and modern neuroscience. This unique formulation blends 11 ingredients—including Bacopa Monnieri, Alpha Lipoic Acid, and key nerve-regenerating compounds—positioning Sciaticyl as a leading curiosity point for those seeking non-surgical options. As nerve pain awareness grows in 2025, researchers and consumers alike are exploring how nutritional support may play a role in long-term sciatica recovery, vitality, and freedom from discomfort.

VICTORIA, Seychelles, 03 août 2025 (GLOBE NEWSWIRE) -- Bitget, la principale plateforme d’échange de cryptomonnaies et société Web3 au monde, a lancé sa nouvelle fonctionnalité d’achat récurrent. Celle-ci permet de mettre en place un plan d’investissement systématique, offrant ainsi aux utilisateurs la possibilité de programmer des achats automatisés de cryptomonnaies à l’aide de cartes Visa et Mastercard. Cette fonctionnalité est conçue pour aider les utilisateurs à constituer des portefeuilles de cryptomonnaies sur le long terme en toute simplicité, en appliquant une stratégie éprouvée connue sous le nom de Dollar Cost Averaging (DCA), une méthode qui a historiquement généré des rendements pouvant atteindre 30 % ou plus dans les cycles de marché haussiers.

VICTORIA, Seychelles, 03 août 2025 (GLOBE NEWSWIRE) -- Bitget, la célèbre plateforme d’échange de cryptomonnaies et société Web3, publie aujourd’hui en collaboration avec Bitcoin.com un guide éducatif intitulé « Crypto Derivatives 101 – Market Breakdown: Who’s Winning the Race? » (Les dérivés cryptographiques 101 – Analyse du marché : qui mène la course ?). Conçu pour aider les nouveaux venus à s’y retrouver sur ce marché en pleine expansion, ce guide met également en avant le leadership de Bitget, dont la part de marché a doublé pour atteindre 7,2 % en 2025, contre 4,6 % au début -de- l’année.

NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation (NASDAQ:NEOG), Alto Neuroscience, Inc. (NYSE:ANRO), RxSight, Inc. (NASDAQ:RXST), and Replimune Group, Inc. (NASDAQ:REPL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Basel, 01 August 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III Archway study, of Susvimo® (ranibizumab injection) for the treatment of people with nAMD.¹ Results show that Susvimo’s immediate and predictable durability was sustained over five years, with approximately 95% of people receiving treatment every six months requiring no supplemental treatment before each refill. The data were presented at the American Society of Retina Specialists (ASRS) 2025 Annual Meeting in Long Beach, California, United States.